EB research

DEBRA UK is the largest UK funder of epidermolysis bullosa (EB) research. We have invested over £22m and have been responsible, through funding pioneering research and working internationally, for establishing much of what is now known about EB.

We have a vision of a world where no one suffers from the painful skin condition epidermolysis bullosa (EB). Our research strategy focuses on what matters to people living with EB. Our ambition is to find treatments to lessen the day-to-day impact of EB, and cures to eradicate EB. We will fund science of the highest quality across the world that has the potential to deliver for EB patients.